Abstract
Selenium (Se) supplementation has been suggested in treating autoimmune thyroid disease and orbitopathy. We sought to investigate perceptions and practices of Se prescription patterns in thyroid disease across three regions in Africa and Asia.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
